Nindanib 150 Capsule is used to manage idiopathic pulmonary fibrosis (IPF), a chronic and debilitating lung disease that causes progressive scarring and stiffness of the lungs. This medicine belongs to the category of anti-fibrotic medicines and works by inhibiting multiple growth factor receptors, which slows down the cellular pathways responsible for the formation of scar tissue (fibrosis). Beyond IPF, the capsule is also beneficial in handling other progressive chronic fibrosing interstitial lung diseases (ILDs) and systemic sclerosis-associated ILD (SSc-ILD), helping to maintain lung function.
50.1% CHEAPER




















































































